SPAC Overview
Timeline Progress
About
JATT III Acquisition Corp. is a blank-check company seeking an unidentified initial business combination. It intends to focus on healthcare and healthcare-related businesses, particularly biotechnology and broader life sciences, including businesses using data-driven approaches to improve therapeutic discovery and development.
Investment Focus
Healthcare, Biopharmaceuticals
The terms and the filing trail behind JATT III ACQUISITION CORP
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Sponsors
Leadership
Underwriters
Extended Team Information
Led by Chairman and CEO Someit Sidhu, a life-sciences entrepreneur and investor with prior SPAC and biotech leadership experience, and CFO Nicholas Fernandez, with over 20 years in finance and operations. The director nominees bring investment-banking and healthcare, biotechnology and life-sciences investing experience.